0001415889-14-000788.txt : 20140311 0001415889-14-000788.hdr.sgml : 20140311 20140311171521 ACCESSION NUMBER: 0001415889-14-000788 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140307 FILED AS OF DATE: 20140311 DATE AS OF CHANGE: 20140311 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 061376651 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11085 TORREYANA ROAD STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-558-2871 MAIL ADDRESS: STREET 1: 11085 TORREYANA ROAD STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Moore Terrence O CENTRAL INDEX KEY: 0001454276 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50768 FILM NUMBER: 14685108 MAIL ADDRESS: STREET 1: C/O ACADIA PHARMACEUTICALS INC STREET 2: 3911 SORRENTO VALLEY BLVD CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 form4-03112014_020312.xml X0306 4 2014-03-07 0001070494 ACADIA PHARMACEUTICALS INC ACAD 0001454276 Moore Terrence O 11085 TORREYANA ROAD #100 SAN DIEGO CA 92121 false true false false EVP, CHIEF COMMERCIAL OFFICER Stock Option (right to buy) 27.20 2014-03-07 4 A 0 35000 0 A 2024-03-06 Common Stock 35000 35000 D 25% of the shares subject to the Stock Option vest and become exercisable on March 7, 2015. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments. /s/ Glenn F. Baity, Attorney-in-Fact 2014-03-11